Clinical Trial Details
| Trial ID: | L3220 |
| Source ID: | NCT02345239 |
| Associated Drug: | Pantoprazole |
| Title: | Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus |
| Interventions: | DRUG: Pantoprazole |
| Outcome Measures: | Primary: Mean 24-hour glucose level, 7 days|Mean post-prandial glucose excursion, 7 days | Secondary: Mean Mean 24-hour glucose level, after discontinuation of pantoprazole, day 6 and 7|Postprandial glucose excursion, after discontinuation of pantoprazole, day 6 and 7 |
| Sponsor/Collaborators: | Sponsor: Dr. Waheed Rehman |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 14 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2015-02 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2015-01-26 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT02345239 |
